Severe asthma in adults: what are the important questions?

[1]  Martyn R Partridge,et al.  British Guideline on the Management of Asthma , 2008, Thorax.

[2]  I. Rahman,et al.  Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. , 2006, Pharmacology & therapeutics.

[3]  R. Folz,et al.  A novel bronchial ring bioassay for the evaluation of small airway smooth muscle function in mice. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[4]  S. Dahlén,et al.  Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone propionate. , 2006, The Journal of allergy and clinical immunology.

[5]  M. Hasegawa,et al.  Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[6]  K. Lødrup Carlsen,et al.  Soluble CD14 at 2 yr of age: Gender‐related effects of tobacco smoke exposure, recurrent infections and atopic diseases , 2006, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[7]  W. Cushman,et al.  Resistant or Difficult‐to‐Treat Hypertension , 2006, The Journal of Clinical Hypertension.

[8]  Deborah Jarvis,et al.  Prognostic factors of asthma severity: a 9-year international prospective cohort study. , 2006, The Journal of allergy and clinical immunology.

[9]  S. Johnston.  Macrolide antibiotics and asthma treatment. , 2006, The Journal of allergy and clinical immunology.

[10]  I. Buchan,et al.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. , 2006, JAMA.

[11]  E. Bel.  "Hot stuff": bronchial thermoplasty for asthma. , 2006, American journal of respiratory and critical care medicine.

[12]  A. McWilliams,et al.  Bronchial thermoplasty for asthma. , 2006, American journal of respiratory and critical care medicine.

[13]  K. Rabe,et al.  Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma , 2006, European Respiratory Journal.

[14]  Choon-Sik Park,et al.  A disintegrin and metalloproteinase 33 protein in patients with asthma: Relevance to airflow limitation. , 2006, American journal of respiratory and critical care medicine.

[15]  Vernon M. Chinchilli,et al.  β-Adrenergic Receptor Polymorphisms and Response to Salmeterol , 2006 .

[16]  L. Boulet,et al.  Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations , 2006, European Respiratory Journal.

[17]  I. Adcock,et al.  Update on glucocorticoid action and resistance. , 2006, The Journal of allergy and clinical immunology.

[18]  S. Wenzel,et al.  Managing severe asthma. , 2006, The Journal of allergy and clinical immunology.

[19]  I. Pavord,et al.  Evidence of a role of tumor necrosis factor alpha in refractory asthma. , 2006, The New England journal of medicine.

[20]  W. Busse,et al.  6. Asthma: Factors underlying inception, exacerbation, and disease progression , 2006, Journal of Allergy and Clinical Immunology.

[21]  M. Everard.  The relationship between respiratory syncytial virus infections and the development of wheezing and asthma in children , 2006, Current opinion in allergy and clinical immunology.

[22]  H. Boushey,et al.  Rhinovirus induces airway epithelial gene expression through double-stranded RNA and IFN-dependent pathways. , 2006, American journal of respiratory cell and molecular biology.

[23]  I. Adcock,et al.  Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.

[24]  S. Wenzel,et al.  Gender Differences in IgE-Mediated Allergic Asthma in the Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) Study , 2006, The Journal of asthma : official journal of the Association for the Care of Asthma.

[25]  P. Chanez,et al.  Are overweight asthmatics more difficult to control? , 2005, Allergy.

[26]  A. Woodcock,et al.  Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children , 2005, Thorax.

[27]  P. Howarth,et al.  Tumour necrosis factor (TNFalpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. , 2005, Thorax.

[28]  E. Bleecker,et al.  Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. , 2005, The Journal of allergy and clinical immunology.

[29]  Charles A. Johnson,et al.  Severity assessment in asthma: An evolving concept. , 2005, The Journal of allergy and clinical immunology.

[30]  A. Zwinderman,et al.  Risk factors of frequent exacerbations in difficult-to-treat asthma , 2005, European Respiratory Journal.

[31]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[32]  S. Wenzel,et al.  Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. , 2005, American journal of respiratory and critical care medicine.

[33]  Carolyn A. Lall,et al.  Beneficial and harmful effects of oscillatory mechanical strain on airway smooth muscle. , 2005, Canadian journal of physiology and pharmacology.

[34]  L. Palmer,et al.  Diminished lipoxin biosynthesis in severe asthma. , 2005, American journal of respiratory and critical care medicine.

[35]  W. Hop,et al.  Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. , 2005, American journal of respiratory and critical care medicine.

[36]  J. Uddin,et al.  Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[37]  C. Lemière,et al.  Differences in airway remodeling between subjects with severe and moderate asthma. , 2005, The Journal of allergy and clinical immunology.

[38]  R. Scott,et al.  Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma. , 2005, American journal of respiratory and critical care medicine.

[39]  L. Borish,et al.  Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[40]  P. Gibson,et al.  Interleukin-10 gene expression in acute virus-induced asthma. , 2005, American journal of respiratory and critical care medicine.

[41]  J. Malo.  Asthma may be more severe if it is work-related. , 2005, American journal of respiratory and critical care medicine.

[42]  P. Thompson,et al.  Plasma concentrations of dietary and nondietary antioxidants are low in severe asthma , 2005, European Respiratory Journal.

[43]  P. Sly,et al.  Lyn-Deficient Mice Develop Severe, Persistent Asthma: Lyn Is a Critical Negative Regulator of Th2 Immunity 1 , 2005, The Journal of Immunology.

[44]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[45]  L. Boulet,et al.  Patterns and determinants of compliance with inhaled steroids in adults with asthma. , 2005, Canadian respiratory journal.

[46]  E. Cook,et al.  Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis. , 2005, The Journal of allergy and clinical immunology.

[47]  E. Ford.  Current reviews of allergy and clinical immunology , 2005 .

[48]  J Bousquet,et al.  Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE , 2005, Allergy.

[49]  R. Poulton,et al.  Sex differences in the relation between body mass index and asthma and atopy in a birth cohort. , 2005, American journal of respiratory and critical care medicine.

[50]  S. Wenzel,et al.  Increased TGF-β2 in severe asthma with eosinophilia , 2005 .

[51]  J. Bousquet,et al.  Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound. , 2005, The Journal of allergy and clinical immunology.

[52]  N. Thomson,et al.  Asthma and cigarette smoking , 2004, European Respiratory Journal.

[53]  E. Israel,et al.  Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial , 2004, The Lancet.

[54]  L. Grinberg,et al.  Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. , 2004, American journal of respiratory and critical care medicine.

[55]  N. Zamel,et al.  Effect of Fluticasone/Salmeterol and Monteleukast on Total Exhaled, Bronchial, and Alveolar Nitric Oxide in Asthmatics , 2004 .

[56]  S. Wenzel,et al.  Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. , 2004, The American journal of pathology.

[57]  N. Zamel,et al.  Risk factors for near-fatal asthma. , 2004, Chest.

[58]  A. Zwinderman,et al.  "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. , 2004, American journal of respiratory and critical care medicine.

[59]  M. Bihl,et al.  Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. , 2004, The New England journal of medicine.

[60]  M. Sanak,et al.  Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. , 2004, The Journal of allergy and clinical immunology.

[61]  Anticholinergic agents for chronic asthma in adults. , 2004, The Cochrane database of systematic reviews.

[62]  I. Adcock,et al.  Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma. , 2004, American journal of respiratory and critical care medicine.

[63]  S. Gabriel,et al.  Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. , 2004, Human molecular genetics.

[64]  D. Postma,et al.  Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[65]  S. Tsiodras,et al.  Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma , 2004, European Respiratory Journal.

[66]  S. Shore,et al.  Obesity and asthma: directions for research. , 2004, American journal of respiratory and critical care medicine.

[67]  J. Bousquet,et al.  Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[68]  J. Fredberg.  Bronchospasm and its biophysical basis in airway smooth muscle , 2004, Respiratory research.

[69]  E. Silverman,et al.  Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. , 2004, Proceedings of the American Thoracic Society.

[70]  P. Barnes.  Corticosteroid resistance in airway disease. , 2004, Proceedings of the American Thoracic Society.

[71]  I. Adcock,et al.  Glucocorticoids: effects on gene transcription. , 2004, Proceedings of the American Thoracic Society.

[72]  S. Wenzel,et al.  Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. , 2004, The Journal of allergy and clinical immunology.

[73]  E. Bel.  Clinical phenotypes of asthma. , 2004, Current opinion in pulmonary medicine.

[74]  A. Custovic,et al.  Allergens, viruses, and asthma exacerbations. , 2004, Proceedings of the American Thoracic Society.

[75]  P. Gibson,et al.  Azoles for allergic bronchopulmonary aspergillosis associated with asthma. , 2004, The Cochrane database of systematic reviews.

[76]  J. Bousquet,et al.  High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma. , 2003, Respiratory medicine.

[77]  D. Postma,et al.  The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma , 2003, European Respiratory Journal.

[78]  J. Bousquet,et al.  Glucocorticoid receptor-binding characteristics in severe asthma , 2003, European Respiratory Journal.

[79]  S. Dahlén,et al.  Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. , 2003, The Journal of allergy and clinical immunology.

[80]  S. Wenzel.  Severe asthma: epidemiology, pathophysiology and treatment. , 2003, The Mount Sinai journal of medicine, New York.

[81]  I. Sayers,et al.  Inhaled corticosteroids and long acting β2 agonists can help patients with COPD , 2003, Thorax.

[82]  R. Djukanović,et al.  The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[83]  F. Ricciardolo,et al.  Multiple roles of nitric oxide in the airways , 2003, Thorax.

[84]  P. Gibson,et al.  Gastro-oesophageal reflux treatment for asthma in adults and children. , 2003, The Cochrane database of systematic reviews.

[85]  T. Casale,et al.  Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma. , 2003, The Journal of allergy and clinical immunology.

[86]  P. Howarth,et al.  Increased expression of p21(waf) cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. , 2003, American journal of respiratory cell and molecular biology.

[87]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[88]  I. Pavord,et al.  Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids , 2002, Thorax.

[89]  A. James,et al.  Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma , 2002, Thorax.

[90]  Richard J Martin,et al.  Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. , 2002, Chest.

[91]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[92]  A. James,et al.  Distribution and degranulation of airway mast cells in normal and asthmatic subjects , 2002, European Respiratory Journal.

[93]  Christopher E Brightling,et al.  A comparison of the validity of different diagnostic tests in adults with asthma. , 2002, Chest.

[94]  P Godard,et al.  Costs of asthma are correlated with severity: a 1-yr prospective study , 2002, European Respiratory Journal.

[95]  P. Gibson,et al.  Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma , 2002, European Respiratory Journal.

[96]  R. Pauwels,et al.  Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. , 2002, American journal of respiratory and critical care medicine.

[97]  P. Henricks,et al.  Reactive oxygen species as mediators in asthma. , 2001, Pulmonary pharmacology & therapeutics.

[98]  I. Adcock,et al.  TGFβ1 allele association with asthma severity , 2001, Human Genetics.

[99]  W. Busse,et al.  Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. , 2001, The Journal of allergy and clinical immunology.

[100]  R. Townley,et al.  The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics. , 2001, The European respiratory journal.

[101]  P. Barnes,et al.  Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial , 2001, The Lancet.

[102]  L. Boulet,et al.  Evaluation of two different educational interventions for adult patients consulting with an acute asthma exacerbation. , 2001, American journal of respiratory and critical care medicine.

[103]  P. Gibson,et al.  Heterogeneity of airway inflammation in persistent asthma : evidence of neutrophilic inflammation and increased sputum interleukin-8. , 2001, Chest.

[104]  A. Zwinderman,et al.  Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection. , 2001, The Journal of allergy and clinical immunology.

[105]  E. Bel,et al.  Similar psychological characteristics in mild and severe asthma. , 2001, Journal of psychosomatic research.

[106]  C. Lemière,et al.  Persistent specific bronchial reactivity to occupational agents in workers with normal nonspecific bronchial reactivity. , 2000, American journal of respiratory and critical care medicine.

[107]  J. Virchow,et al.  Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. , 2000, American journal of respiratory and critical care medicine.

[108]  C. Jenkins,et al.  Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.

[109]  J. Spinelli,et al.  Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. , 2000, The Journal of allergy and clinical immunology.

[110]  P. Howarth,et al.  Involvement of the epidermal growth factor receptor in epithelial repair in asthma , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[111]  M. Kraft,et al.  The role of bacterial infections in asthma. , 2000, Clinics in chest medicine.

[112]  G. Joos,et al.  Role of tachykinins in asthma , 2000, Allergy.

[113]  S. Spector,et al.  Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. , 2000, American journal of respiratory and critical care medicine.

[114]  G H Guyatt,et al.  Development and validation of a questionnaire to measure asthma control. , 1999, The European respiratory journal.

[115]  D. Postma,et al.  Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society. , 1999, The European respiratory journal.

[116]  Third Expert Panel on theDiagnosis,et al.  Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma , 1997 .

[117]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .